ADIPOQ and Parkinson disease: These data, at least in part, indicate that diabetes-related INS, by interacting with and/or regulating SNCA, PLK2, TH, INSR, IPS1, PPARGC1A, and ADIPOQ, drives IR and modulates PD-pathognomonic neurodegeneration.